Drug Product
Regulatory, Tech Transfer & Support Services
Company Overview
About
Lyomark Pharma GmbH is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in API Manufacturing, Sterile Fill/Finish, Lyophilization
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Germany
Founded:1992
Employees:2,493
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
North America
International Regulatory
EU GMP Certificates
4
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval K971JJ
PMDA · #APR-SAU1MTB5 · 2019-06-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-WCPXSKF3
Issued: 2020-02-02
Expires: 2025-02-23
WHO GMP
World Health Organization
Cert #: CERT-5HE0Y4NX
Issued: 2020-04-13
Expires: 2025-09-07
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-8UO166RM
Issued: 2020-12-19
Expires: 2025-07-06
Loading CDMO intelligence...
Key facts about Lyomark Pharma GmbH
- Lyomark Pharma GmbH is headquartered in Germany.
- Lyomark Pharma GmbH was founded in 1992.
- Lyomark Pharma GmbH has 2,493 employees.
- Lyomark Pharma GmbH's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Lyomark Pharma GmbH
Directory pages this company appears in, each with the full list of matching manufacturers.